查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1835241

心臟幫浦設備市場按設備類別、最終用戶、銷售管道和應用分類－2025-2032 年全球預測

Heart Pump Device Market by Device Category, End User, Sales Channel, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年心臟幫浦設備市場將成長至 186.4 億美元，複合年成長率為 16.39%。

主要市場統計數據
基準年2024年 55.3億美元
預計2025年 64.6億美元
預測年份：2032年 186.4億美元
複合年成長率（%） 16.39%

全面的策略介紹，概述了影響機械循環支援的臨床要求、技術進步和機構壓力

報告首先清楚闡述了在日益成長的臨床需求和不斷發展的技術生態系統中，為何心臟幫浦設備值得策略重點關注。機械循環支援的進步正在改變患者的治療路徑，使更多患者能夠延長生命並改善功能狀態，同時也對設備的安全性、耐用性以及與數位醫療平台的整合提出了新的要求。臨床醫生、醫院管理人員和設備製造商正在應對一系列臨床需求、監管審查和供應鏈複雜性，這些因素將決定他們近期的營運格局。

雖然全人工心臟和輔助人工心臟等設備的臨床證據已得到充分證實，但微型化、生物相容性材料、感測器控制和遠端監控等技術創新正在重塑現代市場。這些技術進步正在擴大適應症，使其能夠在門診病人和門診手術中心使用。此外，付款人期望與證據生成之間的相互作用促使製造商優先考慮真實世界的性能數據和基於價值的治療結果。因此，將創新轉化為持久的商業性成功需要整合臨床路徑、報銷策略和生產可擴展性的策略規劃。

因此，相關人員應該採取以患者和系統為中心的觀點，預測護理地點的變化、設備和軟體生態系統的融合以及對植入後追蹤的不斷提高的期望。本介紹透過強調影響心臟幫浦設備生態系統所有參與者策略選擇的核心力量來為以下章節建立背景：臨床需求、技術進步、監管動態和供應鏈壓力。

深入檢驗技術創新、不斷發展的護理服務以及重新定義心臟泵治療競爭優勢的證據需求

在技​​術突破、醫療服務模式不斷演變以及對長期療效日益關注等諸多因素的共同推動下，心臟幫浦領域正在經歷重大變革。微創植入技術和更緊湊的幫浦設計正在擴大患者群體，同時降低手術全期風險，從而推動從單純住院治療轉向門診和門診治療。同時，嵌入式感測器和遠端監控平台的普及使得持續的生理監測成為可能，有助於早期療育，並降低再入院率——這是醫療保健系統的關鍵績效指標。

同樣，將目標療法發展成為永續的治療途徑，而非移植前的過渡，也至關重要。隨著器械耐用性的提高和生物相容性的進步降低併發症率，即使對於不適合移植的患者，臨床醫生也越來越有可能考慮機械支持。這種轉變推動了對強大的長期管理模式的需求，包括遠端遠端檢測、結構化的抗凝血門診和綜合復健計劃。監管趨勢正在不斷調整，以適應器械的漸進式更新和軟體主導的功能，要求製造商將開發藍圖與上市後監管義務和真實世界證據的生成相結合。

同時，相關人員對醫療總成本的期望正促使設備製造商展現超越設備性能的價值。醫院和付款方越來越要求提供將設備使用與縮短住院時間、降低再入院率以及降低後續成本相關聯的數據。因此，策略差異化取決於能否提供臨床有效性以及顯著的健康經濟效益。總而言之，這些變革正在重新定義競爭優勢，使其成為令人信服的臨床結果、可靠的證據生成以及與不斷發展的護理路徑無縫整合的交匯點。

深入評估近期美國關稅行動如何重塑心臟幫浦設備價值鏈的供應鏈、籌資策略和商業性方法

美國在當前政策週期內徵收和調整的關稅，對心臟泵設備生態系統產生了多層次的影響，影響了採購決策、供應商關係和成本結構，但並未統一改變臨床應用的動態。重要的是，針對關鍵子部件和原料的關稅正迫使製造商重新評估供應商多元化，加快替代供應商的資格審查，並考慮透過合約對沖來保護淨利率。對於製造地集中在海外的公司來說，這些關稅制度將促使他們考慮近岸外包、關鍵子組件的垂直整合或策略性庫存緩衝，以維持供應的連續性。

這些貿易摩擦也將對分銷策略和服務模式產生下游影響。醫院和門診中心的採購定價可能會逐步調整，進而影響資本採購週期和治療方法的比較評估。為了保持採用勢頭，醫療設備製造商正在實施配套服務和延長保固期，以吸收部分買方的成本波動，同時尋求契約製造。

醫療器材和耗材價格持續上漲，可能促使人們重新審視報銷途徑和使用標準。因此，要應對關稅的影響，需要採取多管齊下的應對措施，包括增強供應鏈韌性、最佳化定價策略、積極主動地與相關人員溝通，以及有針對性地投資於製造敏捷性。總體而言，美國在此期間的關稅累積影響促使整個心臟泵設備價值鏈的採購、生產和銷售策略重新平衡。

綜合策略細分，以定義跨裝置類別、護理環境、通路和應用的差異化臨床、商業和製造優先事項

細分分析揭示了不同設備類別、護理環境、銷售管道和臨床應用之間的差異化策略重點，從而創造了多種成長和專業化途徑。在設備類別中，全人工心臟和輔助人工心臟之間有明顯差異。後者進一步細分為雙心室、左心室和右心室輔助裝置，每種裝置都有不同的工程複雜性、臨床工作流程和售後需求。這種子類別分類影響製造複雜性和售後市場需求，與左心室系統相比，右側輔助裝置通常具有不同的血流動力學控制和尺寸限制。

終端使用者細分揭示了門診手術中心和醫院之間不同的採購和臨床應用動態。隨著設備配置的演變和手術全期路徑的簡化，門診手術中心逐漸成為低風險手術的中心。銷售管道的差異——直銷與代理商主導——決定了銷售資源的分配和客戶參與策略。直銷通常能夠提供更深入的臨床培訓和更緊密的服務合約整合，而代理銷售則能夠為缺乏完整銷售基礎設施的公司提供更廣泛的地域覆蓋和通路整合。

基於應用的差異化進一步細化了機會集。移植前橋接用例需要與移植中心網路合作，並且通常涉及複雜的患者選擇和短期管理通訊協定。目標療法細分為成人和兒科，強調設備的長期可靠性、患者支持生態系統和生命週期管理計劃。兒科目標療法增加了與生長適應和長期生物相容性相關的監管和設計考量。這些細分領域相結合，使製造商和醫療保健提供者能夠優先投資於與其能力和市場願景在策略上最契合的產品設計、臨床教育和服務模式。

細緻的區域分析考慮了美洲、中東和非洲以及亞太地區不同的監管、報銷和醫療保健服務要求

亞太地區、歐洲以及中東和非洲地區各自呈現不同的機會和法規環境，對商業化和業務策略產生重大影響。在美洲，成熟的三級醫療網路和先進的報銷機制推動了尖端機械循環支援解決方案的採用，從而推動了市場需求。然而，採購週期和醫院預算限制仍然需要令人信服的價值主張和可靠的臨床證據來支持資本投資決策。

中東和非洲地區在監管途徑和醫療保健系統資金籌措表現出差異性，需要製定量身定做的打入市場策略。在西方市場，成熟的監管協調機制和專業的心臟中心有助於精準投放和收集上市後數據，而政府主導的現代化項目和不斷擴張的私人醫院則為一些中東市場提供了機會。在整個非洲，基礎設施低度開發和專科醫生能力有限將導致採用時間更長。

亞太地區呈現出雙重特徵：高度發展的市場和快速發展的醫療保健生態系統。在不斷成長的國內製造能力和戰略夥伴關係關係的支持下，該地區的高所得市場相對較快地採用了創新設備功能和數位化整合。相反，新興市場則優先考慮可負擔性、本地交付和臨床培訓。在這種環境下，成功通常取決於靈活的定價策略、本地化的臨床教育計畫以及能夠支援分散式醫療服務的經銷商網路。這些區域差異共同要求制定量身定做的上市模式，這些模式必須尊重當地的管理體制、報銷現實情況和臨床能力，同時還要建立一個可擴展的營運框架，以適應需求和基礎設施的發展。

前瞻性競爭評估重點在於產品創新、臨床證據生態系統和生命週期服務如何決定機械循環支援領域的領導地位

心臟泵設備生態系統的競爭力日益取決於其將臨床證據、生產規模和卓越的售後服務整合成一致價值提案的能力。領先的公司持續投資於迭代設備改進、感測器監控和遠端系統管理平台，以減輕臨床醫生負擔並改善患者治療效果。同時，新參與企業正在利用顛覆性材料科學、更小的外形規格和軟體主導的控制架構，挑戰關於設備設計和患者選擇的傳統假設。

製造商之間的策略行動包括橫向和縱向夥伴關係、有針對性的收購以確保組件產能，以及與三級醫療中心開展合作臨床項目以加速證據產生。對於那些尋求擴大生產規模並保持靈活性以適應不斷變化的關稅和監管要求的公司而言，合約製造商和專業供應商已成為重要的策略合作夥伴。智慧財產權組合和監管備案是關鍵的差異化因素，尤其是在新型血流動力學控制演算法或生物相容性材料具有臨床或營運優勢的情況下。

服務和生命週期管理能力是競爭的關鍵領域。能夠將設備硬體與強大的培訓、遠端監控、預測性維護和結果報告功能相結合的公司擁有更強大的商業關係和更廣泛的定價策略。最後，兒科專業技能和針對較小患者群體的個人化證據獲取是利基領域，有針對性的投資可以帶來永續的競爭優勢。總體而言，產品差異化、證據產生、供應鏈彈性和卓越服務的結合將決定哪些公司將在高危急症護理醫院市場和新興門診市場中佔據領先地位。

以下是領導者可以採取的一些策略建議，以協調臨床證據產生、供應鏈彈性和服務創新，從而加速採用並保持競爭優勢：

產業領導者應採取投資組合策略，在短期商業化投資與降低風險、提升臨床價值的持久能力之間取得平衡。首先，優先產生可操作的臨床證據，這些證據不僅能證明設備性能，還能證明其降低下游利用率和改善病患報告結果的能力。將遠端監控資料和標準化結果指標納入付款人對話，可以增強報銷地位並縮短採購決策週期。

第二，透過多元化供應商、確定關鍵零件的二級資訊來源以及考慮高風險次組件的本地組裝或近岸外包來增強供應鏈的韌性。這些措施將減輕關稅的影響，並支持快速應對監管和疫情帶來的干擾。第三，設計反映最終用戶實際狀況的商業模式。這意味著要在銷售量，同時在新興和成本敏感型市場建立經銷商夥伴關係並提供靈活的定價。

第四，擴展服務範圍，包括遠端患者管理、預測性維護和以結果為導向的培訓項目，以創造經常性收益來源並深化客戶關係。第五，制定針對小兒科市場的策略，該市場臨床差異化和競爭有限，在確保設備架構能夠實現成長和長期生物相容性的同時，證明高階定位的合理性。最後，積極與監管機構和付款方合作，共同開發一個上市後監測框架，在保障病人安全的同時支持迭代改進。透過同時實施這些建議，企業可以將技術創新轉化為永續的商業性優勢和系統級價值。

採用嚴格的混合方法研究途徑，整合臨床醫師訪談、監管分析、供應鏈映射和證據三角測量，以檢驗策略結論

本分析的基礎研究採用混合方法，整合了主要相關人員訪談、臨床文獻綜述、監管申報分析和供應鏈圖譜，以確保對研究結果進行三角比較。主要訪談對象包括心臟外科醫師、心臟衰竭循環系統、採購經理、製造主管和臨床試驗負責人等多位專家，旨在了解醫療保健機構的營運現狀和策略重點。這些定性見解輔以同行評審臨床研究、註冊數據和特定器械上市後報告的系統性回顧，從而將器械性能敘述與已發表的證據聯繫起來。

透過審查公告、指導文件和付款人政策聲明，分析了監管和報銷格局，從而能夠映射各主要司法管轄區的核准和申請考慮。供應鏈韌性評估結合了供應商網路分析、貿易流量數據和公開訊息，以識別瓶頸、單一來源依賴以及潛在的緩解措施，例如替代供應商和本地生產。透過分析專利格局、產品發布追蹤和公司公告，評估了競爭格局，以捕捉合作夥伴關係、授權協議和製造投資等策略舉措。

在整個研究週期中，研究結果經過專家反覆檢驗，並與多個資訊來源進行最後覆核，以減少偏差並確保準確性。公共資料中的缺失部分透過針對性的專家訪談得以具體化。這種方法最終得出了全面的、基於證據的結論，既反映了臨床現實，也反映了商業性需求。

簡潔的結論綜合了技術創新、證據生成和操作彈性如何融合以決定機械循環支援的成功。

摘要，心臟幫浦設備產業正處於曲折點，臨床創新、醫療服務轉型和營運韌性必須齊頭並進，才能實現更廣泛的應用並造福患者。雖然技術進步正在擴大適應症並帶來新的照護環境，但成功的商業化將取決於能否展現長期價值、管理複雜的供應鏈，以及整合服務以支持患者和醫療服務提供者的全程照護。同時，細分洞察凸顯了產品需求和上市策略的明顯差異。

綜上所述，這些動態表明，那些致力於產生可操作證據、建立適應性製造模式並提供卓越生命週期服務的組織將最有可能主導。透過專注於決策者關注的臨床和經濟因素，並加強營運基礎以減輕外部衝擊，相關人員可以將創新轉化為改善的患者治療效果和永續的商業性回報。本文的結論為規劃和有針對性地執行產品開發、上市和上市後支援的後續步驟提供了策略基礎。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 擴大採用具有無線充電功能的完全植入式左心室輔助裝置
  • 擴大使用遠端監控平台來追蹤心臟幫浦患者的即時血流動力學數據
  • 磁浮葉輪技術開發，減少機械循環支持過程中的血液損傷
  • 擴大左心室補助人工心臟的適應症，包括中度心臟衰竭和門診病人
  • 整合人工智慧演算法，對心肺支援設備效能和病患結果進行預測分析
  • 經皮右心室輔助系統的出現，為右心臟衰竭提供微創支持
  • 我們專注於生物相容性表面塗層，以最大限度地減少血栓症形成並減少長期抗凝血治療的需要。
  • 設備製造商和遠端醫療提供者之間的合作，以加強遠距患者管理

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第 8 章：心臟幫浦設備市場（依設備類別）

  • 全人工心臟
  • 心室輔助裝置
    • 雙心室輔助裝置
    • 左心室補助人工心臟
    • 右心室輔助裝置

第 9 章：心臟幫浦設備市場（依最終用戶分類）

  • 門診手術中心
  • 醫院

第 10 章心臟幫浦設備市場依銷售管道

  • 直銷
  • 經銷商銷售

第11章心臟幫浦設備市場（依應用）

  • 移植橋樑
  • 目的地療法
    • 成人
    • 孩子們

第12章心臟幫浦設備市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 13 章：心臟幫浦設備市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章心臟幫浦設備市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Abbott Laboratories
    • Medtronic plc
    • Abiomed, Inc.
    • LivaNova PLC
    • Getinge AB
    • Terumo Corporation
    • B. Braun Melsungen AG
    • SynCardia Systems, LLC
    • Carmat SA
    • Berlin Heart GmbH
Product Code: MRR-437E9896A563

The Heart Pump Device Market is projected to grow by USD 18.64 billion at a CAGR of 16.39% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.53 billion
Estimated Year [2025] USD 6.46 billion
Forecast Year [2032] USD 18.64 billion
CAGR (%) 16.39%

A comprehensive strategic introduction outlining the clinical imperatives, technological advances, and systemic pressures reshaping mechanical circulatory support delivery

This report opens with a clear framing of why heart pump devices warrant concentrated strategic attention amid intensifying clinical demand and evolving technology ecosystems. Advances in mechanical circulatory support have shifted patient pathways, enabling more patients to live longer and with improved functional status, while simultaneously creating new imperatives for device safety, durability, and integration with digital care platforms. Clinicians, hospital administrators, and device manufacturers are navigating a confluence of clinical need, regulatory scrutiny, and supply chain complexity that together define the near-term operational landscape.

While the clinical rationale for devices such as total artificial hearts and ventricular assist devices is well established, the contemporary market is being reshaped by innovations in miniaturization, biocompatible materials, sensor-enabled controls, and telemonitoring. These technological improvements are extending indications and enabling greater use in outpatient and ambulatory surgical center settings. Moreover, the interplay between payer expectations and evidence generation is driving manufacturers to prioritize real-world performance data and value-based outcomes. Consequently, strategic planning must integrate clinical pathways, reimbursement strategies, and manufacturing scalability to convert innovation into durable commercial success.

As a result, stakeholders should adopt a patient- and system-centered view that anticipates shifting treatment locations, converging device and software ecosystems, and heightened expectations for post-implant follow-up. This introduction establishes the context for subsequent sections by highlighting the core forces-clinical need, technological progress, regulatory dynamics, and supply chain pressures-that together shape strategic choices for all participants in the heart pump device ecosystem.

An incisive examination of technological innovation, care delivery evolution, and evidence demands that are redefining competitive advantage in heart pump therapy

The landscape for heart pump devices is undergoing transformative shifts driven by a combination of technological breakthroughs, evolving care delivery models, and increasing emphasis on long-term outcomes. Minimally invasive implantation techniques and more compact pump architectures are broadening candidate populations while reducing perioperative risk, which in turn supports a transition from exclusively inpatient procedures toward ambulatory and outpatient settings. Concurrently, the proliferation of embedded sensors and remote monitoring platforms is enabling continuous physiologic surveillance, facilitating early intervention and reducing readmission rates, which are critical performance indicators for health systems.

Equally consequential is the maturation of destination therapy as a sustained treatment pathway rather than a bridge to transplant. As device durability improves and biocompatibility advances lower complication rates, clinicians are more likely to consider mechanical support for patients who are not transplant candidates. This shift increases the need for robust long-term management models, including remote telemetry, structured anticoagulation clinics, and integrated rehabilitation programs. Regulatory pathways are adapting to accommodate incremental device updates and software-driven features, requiring manufacturers to align development roadmaps with post-market surveillance obligations and real-world evidence generation.

In parallel, stakeholder expectations around total cost of care are prompting device makers to demonstrate value beyond device performance. Hospitals and payers increasingly demand data that correlate device use with reductions in length of stay, rehospitalizations, and downstream costs. Therefore, strategic differentiation will hinge on the ability to deliver clinical efficacy alongside demonstrable health-economic benefits. Taken together, these transformative shifts redefine competitive advantage as the intersection of compelling clinical outcomes, robust evidence generation, and seamless integration into evolving care pathways.

A detailed assessment of how recent United States tariff dynamics are reshaping supply chains, sourcing strategies, and commercial approaches across the heart pump device value chain

The imposition and adjustment of tariffs in the United States during the current policy cycle have imposed layered effects on the heart pump device ecosystem, influencing component sourcing decisions, supplier relationships, and cost structures without uniformly altering clinical adoption dynamics. Importantly, tariffs that target key subcomponents or raw materials pressure manufacturers to reassess supplier diversification, accelerate qualification of alternate vendors, and consider contractual hedges that protect margins. For companies with concentrated offshore manufacturing footprints, such tariff regimes stimulate deliberations about nearshoring, vertical integration of critical subassemblies, or strategic inventory buffering to maintain supply continuity.

These trade-related frictions also have downstream implications for distribution strategies and service models. Hospitals and ambulatory centers may experience phased adjustments in procurement pricing that influence capital purchase cycles and comparative evaluations across therapeutic options. To preserve adoption momentum, device companies are increasingly implementing bundled-service propositions and extended warranties that absorb some cost volatility for buyers, while simultaneously seeking operational efficiencies in manufacturing and logistics. Furthermore, tariffs can complicate collaborative arrangements with contract manufacturers and foreign research partners by introducing administrative and compliance overhead that lengthens time-to-market for incremental product updates.

Regulatory and payer stakeholders react to cost dynamics as well; sustained increases in equipment and consumable prices can prompt closer scrutiny of reimbursement pathways and utilization criteria. Consequently, navigating tariff impacts requires a multifaceted response that combines supply-chain resilience, pricing strategy refinement, proactive stakeholder communication, and targeted investments in manufacturing agility. In sum, the cumulative tariff effects in the United States during this period have catalyzed a rebalancing of sourcing, production, and commercial tactics across the heart pump device value chain.

A strategic segmentation synthesis that clarifies differentiated clinical, commercial, and manufacturing priorities across device categories, care settings, channels, and applications

Segmentation analysis reveals differentiated strategic priorities across device categories, care settings, sales channels, and clinical applications that together create multiple routes to growth and specialization. Within device category, there is a clear distinction between total artificial hearts and ventricular assist devices; the latter further segments into biventricular, left ventricular, and right ventricular assist devices, each with distinct engineering complexity, clinical workflows, and follow-on service demands. These intra-category distinctions influence manufacturing complexity and aftermarket needs, with right-sided support typically featuring different hemodynamic controls and size constraints compared with left ventricular systems.

End-user segmentation highlights divergent procurement and clinical adoption dynamics between ambulatory surgical centers and hospitals. Hospitals remain the primary locus for advanced implantations due to their intensive care capabilities and multidisciplinary teams, whereas ambulatory surgical centers represent a growing locus for lower-risk procedures as device profiles evolve and perioperative pathways become more streamlined. Sales channel differentiation between direct sales and distributor-led models shapes commercial resource allocation and customer engagement tactics. Direct sales often enable deeper clinical training and tighter integration of service contracts, while distributor sales can provide broader geographic reach and channel moderation for companies without a full sales infrastructure.

Application-based distinctions further refine opportunity sets. The bridge-to-transplant use case requires alignment with transplant center networks and often entails complex patient selection and short-term management protocols. Destination therapy, which is subdivided into adult and pediatric populations, places a premium on long-term device reliability, patient support ecosystems, and life-cycle management programs. Pediatric destination therapy introduces additional regulatory and design considerations related to growth accommodation and long-term biocompatibility. By synthesizing these segmentation lenses, manufacturers and providers can prioritize investments in product design, clinical education, and service models that correspond to the highest strategic fit for their capabilities and market aspirations.

A nuanced regional analysis describing differentiated regulatory, reimbursement, and care delivery imperatives across the Americas, Europe Middle East and Africa, and Asia Pacific

Regional dynamics offer varied opportunity sets and regulatory environments that materially influence commercialization and operational strategies across the Americas, Europe Middle East and Africa, and Asia Pacific. In the Americas, demand drivers are underpinned by established tertiary care networks and advanced reimbursement mechanisms that facilitate the adoption of cutting-edge mechanical circulatory support solutions; however, procurement cycles and hospital budget constraints still require compelling value narratives and robust clinical evidence to support capital investment decisions.

The Europe Middle East and Africa region exhibits heterogeneity in regulatory pathways and health system financing, which necessitates tailored market entry strategies. In Western European markets, established regulatory harmonization and specialized cardiac centers enable focused launches and post-market data collection, while certain Middle Eastern markets present opportunities through government-led modernization programs and private hospital expansion. Across Africa, nascent infrastructure and limited specialist capacity imply longer timelines for adoption, with opportunities often tied to capacity building, training partnerships, and phased technology transfer.

Asia Pacific presents a dual landscape of highly advanced markets alongside rapidly developing care ecosystems. High-income markets within the region adopt innovative device features and digital integration relatively quickly, supported by growing domestic manufacturing capabilities and strategic partnerships. Conversely, emerging markets prioritize affordability, local serviceability, and clinical training; success in these settings often hinges on adaptive pricing strategies, localized clinical education programs, and distributor networks that can support decentralized care delivery. Collectively, these regional distinctions require calibrated go-to-market models that respect local regulatory regimes, reimbursement realities, and clinical capacity, while allowing for scalable operational frameworks that can be adapted as demand and infrastructure evolve.

A forward-looking competitive assessment highlighting how product innovation, clinical evidence ecosystems, and lifecycle services determine leadership in mechanical circulatory support

Competitive dynamics in the heart pump device ecosystem are increasingly defined by the ability to integrate clinical evidence, manufacturing scale, and aftermarket service excellence into a coherent value proposition. Leading organizations continue to invest in iterative device improvements, sensor-enabled monitoring, and remote management platforms that reduce clinician burden and improve patient outcomes. Concurrently, emerging entrants are leveraging disruptive materials science, smaller form factors, and software-driven control architectures to challenge legacy assumptions about device design and patient selection.

Strategic behavior among manufacturers includes horizontal and vertical partnerships, targeted acquisitions to secure component capabilities, and collaborative clinical programs with tertiary centers to accelerate evidence generation. Contract manufacturers and specialist suppliers have become critical strategic partners for firms seeking to scale production while maintaining flexibility to adapt to evolving tariffs and regulatory requirements. Intellectual property portfolios and regulatory filings serve as key differentiators, particularly where novel hemodynamic control algorithms or biocompatible materials confer clinical or operational advantages.

Service and lifecycle management capabilities are a major competitive battleground. Organizations that can bundle device hardware with robust training, remote monitoring, predictive maintenance, and outcome reporting create stickier commercial relationships and more defensible pricing positions. Finally, access to specialized pediatric expertise and evidence tailored to smaller patient cohorts represents a niche where targeted investments can yield durable competitive advantage. Overall, the combination of product differentiation, evidence generation, supply chain resilience, and service excellence will determine which companies lead in both high-acuity hospital markets and emerging ambulatory settings.

Actionable strategic recommendations for leaders to align clinical evidence generation, supply chain resilience, and service innovation to accelerate adoption and sustain competitive advantage

Industry leaders should adopt a portfolio approach that balances near-term commercialization with investments in durable capabilities that reduce risk and increase clinical value. First, prioritize the generation of pragmatic clinical evidence that demonstrates not only device performance but also the capacity to reduce downstream utilization and improve patient-reported outcomes. Integrating remote monitoring data and standardized outcome metrics into payer conversations will strengthen reimbursement positioning and shorten procurement decision cycles.

Second, fortify supply chain resilience by diversifying supplier bases, qualifying secondary sources for critical components, and exploring localized assembly or nearshoring for high-risk subassemblies. These measures mitigate tariff exposure and support faster response to regulatory or pandemic-driven disruptions. Third, design commercial models that reflect the realities of the end-user landscape: invest in direct-sales capabilities and clinical education in high-volume tertiary centers, while building distributor partnerships and adaptive pricing for emerging and cost-sensitive markets.

Fourth, expand service offerings that encompass remote patient management, predictive maintenance, and outcome-focused training programs to create recurring revenue streams and deepen customer relationships. Fifth, pursue targeted pediatric strategies where clinical differentiation and limited competition can justify premium positioning, while ensuring device architectures account for growth and long-term biocompatibility. Finally, engage proactively with regulators and payers to co-develop post-market surveillance frameworks that support iterative improvement while maintaining patient safety. By executing these recommendations in parallel, companies can convert technological innovation into sustainable commercial advantage and system-level value.

A rigorous mixed-methods research approach integrating clinician interviews, regulatory analysis, supply chain mapping, and evidence triangulation to validate strategic conclusions

The research underpinning this analysis draws on a mixed-methods approach that integrates primary stakeholder interviews, clinical literature review, regulatory filing analysis, and supply chain mapping to ensure robust triangulation of findings. Primary interviews were conducted with a diverse set of experts, including cardiac surgeons, heart failure cardiologists, procurement directors, manufacturing executives, and clinical trialists, to capture both operational realities and strategic priorities across care settings. These qualitative insights were supplemented by a systematic review of peer-reviewed clinical studies, registry data, and device-specific post-market reports to ground device performance narratives in published evidence.

Regulatory and reimbursement landscapes were analyzed through a review of public filings, guidance documents, and payer policy statements, enabling the mapping of approval and coverage considerations across major jurisdictions. Supply chain resilience assessments incorporated supplier network analysis, trade flow data, and public disclosures to identify bottlenecks, single-source dependencies, and potential mitigants such as alternate vendors or localized production. Competitive dynamics were evaluated through patent landscaping, product launch tracking, and analysis of corporate announcements to understand strategic moves such as partnerships, licensing agreements, and manufacturing investments.

Throughout the research lifecycle, findings were iteratively validated with subject-matter experts and cross-checked against multiple information sources to reduce bias and ensure accuracy. Where gaps in public data existed, targeted expert elicitation provided contextual clarity. This methodology ensures that conclusions are grounded in a comprehensive evidence base that reflects both clinical realities and commercial imperatives.

A succinct conclusion that synthesizes how innovation, evidence generation, and operational resilience converge to determine success in mechanical circulatory support

In summary, the heart pump device sector stands at an inflection point where clinical innovation, care delivery transformation, and operational resilience must align to realize broader adoption and patient benefit. Technological progress is enabling expanded indications and new care settings, yet successful commercialization will depend on the capacity to demonstrate long-term value, manage complex supply chains, and integrate services that support patients and providers across the continuum of care. Tariff-induced pressures and regional heterogeneity underscore the importance of supply diversification and localized strategies, while segmentation insights highlight clear differences in product requirements and go-to-market tactics.

Collectively, these dynamics suggest that organizations which invest in pragmatic evidence generation, adaptive manufacturing models, and compelling lifecycle service offerings will be best positioned to lead. By focusing on both the clinical and economic narratives that matter to decision-makers, and by strengthening operational foundations to mitigate external shocks, stakeholders can convert innovation into improved patient outcomes and durable commercial returns. The conclusions drawn here provide a strategic foundation for next-step planning and targeted execution across product development, market entry, and post-market support.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of fully implantable left ventricular assist devices with wireless charging integration
  • 5.2. Increased use of remote monitoring platforms for real-time hemodynamic data tracking in heart pump patients
  • 5.3. Development of magnetically levitated impeller technology to reduce blood trauma in mechanical circulatory support
  • 5.4. Expansion of left ventricular assist device indications to moderate heart failure and ambulatory patient populations
  • 5.5. Integration of artificial intelligence algorithms for predictive analytics in ventricular assist device performance and patient outcomes
  • 5.6. Emerging percutaneous right ventricular assist systems enabling minimally invasive support for right heart failure
  • 5.7. Focus on biocompatible surface coatings to minimize thrombosis and reduce long-term anticoagulation requirements
  • 5.8. Collaborations between device manufacturers and telehealth providers to enhance remote patient management

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Heart Pump Device Market, by Device Category

  • 8.1. Total Artificial Heart
  • 8.2. Ventricular Assist Devices
    • 8.2.1. BiVentricular Assist Devices
    • 8.2.2. Left Ventricular Assist Devices
    • 8.2.3. Right Ventricular Assist Devices

9. Heart Pump Device Market, by End User

  • 9.1. Ambulatory Surgical Centers
  • 9.2. Hospitals

10. Heart Pump Device Market, by Sales Channel

  • 10.1. Direct Sales
  • 10.2. Distributor Sales

11. Heart Pump Device Market, by Application

  • 11.1. Bridge To Transplant
  • 11.2. Destination Therapy
    • 11.2.1. Adult
    • 11.2.2. Pediatric

12. Heart Pump Device Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Heart Pump Device Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Heart Pump Device Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Abbott Laboratories
    • 15.3.2. Medtronic plc
    • 15.3.3. Abiomed, Inc.
    • 15.3.4. LivaNova PLC
    • 15.3.5. Getinge AB
    • 15.3.6. Terumo Corporation
    • 15.3.7. B. Braun Melsungen AG
    • 15.3.8. SynCardia Systems, LLC
    • 15.3.9. Carmat SA
    • 15.3.10. Berlin Heart GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEART PUMP DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. HEART PUMP DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. HEART PUMP DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HEART PUMP DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HEART PUMP DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HEART PUMP DEVICE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 99. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 101. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 103. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 105. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 114. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 116. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 128. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 130. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 170. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 172. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 176. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 180. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 181. AFRICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. AFRICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. AFRICA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 184. AFRICA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 185. AFRICA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 186. AFRICA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 187. AFRICA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. AFRICA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. AFRICA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. AFRICA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. AFRICA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. AFRICA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. AFRICA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 194. AFRICA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. ASEAN HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. ASEAN HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. ASEAN HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 214. ASEAN HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 215. ASEAN HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 216. ASEAN HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 217. ASEAN HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. ASEAN HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. ASEAN HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. ASEAN HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. ASEAN HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. ASEAN HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. ASEAN HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 224. ASEAN HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 225. GCC HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GCC HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GCC HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 228. GCC HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 229. GCC HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 230. GCC HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 231. GCC HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. GCC HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. GCC HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. GCC HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. GCC HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. GCC HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. GCC HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 238. GCC HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 253. BRICS HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. BRICS HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. BRICS HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 256. BRICS HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 257. BRICS HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 258. BRICS HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 259. BRICS HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. BRICS HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. BRICS HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 262. BRICS HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 263. BRICS HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. BRICS HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. BRICS HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 266. BRICS HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 267. G7 HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. G7 HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. G7 HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 270. G7 HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 271. G7 HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 272. G7 HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 273. G7 HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. G7 HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. G7 HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 276. G7 HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 277. G7 HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. G7 HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. G7 HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 280. G7 HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 281. NATO HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. NATO HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. NATO HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 284. NATO HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 285. NATO HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 286. NATO HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 287. NATO HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. NATO HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. NATO HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 290. NATO HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 291. NATO HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. NATO HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. NATO HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 294. NATO HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 298. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 299. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 300. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 301. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 305. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 308. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 309. CANADA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 310. CANADA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 311. CANADA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 312. CANADA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 313. CANADA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. CANADA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 315. CANADA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 316. CANADA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 317. CANADA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. CANADA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. CANADA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 320. CANADA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 321. MEXICO HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 322. MEXICO HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 323. MEXICO HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 324. MEXICO HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 325. MEXICO HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. MEXICO HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. MEXICO HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 328. MEXICO HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 329. MEXICO HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 330. MEXICO HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 331. MEXICO HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 332. MEXICO HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 333. BRAZIL HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 334. BRAZIL HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 335. BRAZIL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 336. BRAZIL HEART PUMP DEVICE MARKET SIZE, BY VENT